Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9C7D

Human monoclonal antibody MAD22-38 bound to the N-terminus of cleaved circumsporozoite protein

Summary for 9C7D
Entry DOI10.2210/pdb9c7d/pdb
DescriptorMonoclonal antibody MAD22-38 Fab Heavy Chain, Monoclonal antibody MAD22-38 Fab Light Chain, Circumsporozoite protein, ... (5 entities in total)
Functional Keywordsantibody, malaria, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight50406.76
Authors
Moskovitz, R.,Wilson, I.A. (deposition date: 2024-06-10, release date: 2024-12-25, Last modification date: 2025-01-22)
Primary citationDacon, C.,Moskovitz, R.,Swearingen, K.,Da Silva Pereira, L.,Flores-Garcia, Y.,Aleshnick, M.,Kanatani, S.,Flynn, B.,Molina-Cruz, A.,Wollenberg, K.,Traver, M.,Kirtley, P.,Purser, L.,Dillon, M.,Bonilla, B.,Franco, A.,Petros, S.,Kritzberg, J.,Tucker, C.,Paez, G.G.,Gupta, P.,Shears, M.J.,Pazzi, J.,Edgar, J.M.,Teng, A.A.,Belmonte, A.,Oda, K.,Doumbo, S.,Krymskaya, L.,Skinner, J.,Li, S.,Ghosal, S.,Kayentao, K.,Ongoiba, A.,Vaughan, A.,Campo, J.J.,Traore, B.,Barillas-Mury, C.,Wijayalath, W.,Idris, A.,Crompton, P.D.,Sinnis, P.,Wilder, B.K.,Zavala, F.,Seder, R.A.,Wilson, I.A.,Tan, J.
Protective antibodies target cryptic epitope unmasked by cleavage of malaria sporozoite protein.
Science, 387:eadr0510-eadr0510, 2025
Cited by
PubMed Abstract: The most advanced monoclonal antibodies (mAbs) and vaccines against malaria target the central repeat region or closely related sequences within the circumsporozoite protein (PfCSP). Here, using an antigen-agnostic strategy to investigate human antibody responses to whole sporozoites, we identified a class of mAbs that target a cryptic PfCSP epitope that is only exposed after cleavage and subsequent pyroglutamylation (pGlu) of the newly formed N terminus. This pGlu-CSP epitope is not targeted by current anti-PfCSP mAbs and is not included in the licensed malaria vaccines. MAD21-101, the most potent mAb in this class, confers sterile protection against infection in a human liver-chimeric mouse model. These findings reveal a site of vulnerability on the sporozoite surface that can be targeted by next-generation antimalarial interventions.
PubMed: 39745947
DOI: 10.1126/science.adr0510
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.99 Å)
Structure validation

232829

PDB entries from 2025-03-12

PDB statisticsPDBj update infoContact PDBjnumon